The pharmaceutical industry is rapidly evolving, with substantial demand for high-quality Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, represents example of this trend. To fulfill this demand, US-based manufacturing services are gaining traction. These providers offer a detailed suite of capabilities, from resear